NR603 Week 3 Case Study (2021)-Graded A+

Three Months Ago: AIC 6.4% Fasting glucose 135mgs/dl Total Cholesterol: 230 (200-239; borderline high) >240 very high Triglycerides 180mgs/dl (less than 150) 150-199 is borderline high Ldl 180 (

Three Months Ago: AIC 6.4% Fasting glucose 135mgs/dl Total Cholesterol: 230 (200-239; borderline high) >240 very high Triglycerides 180mgs/dl (less than 150) 150-199 is borderline high Ldl 180 (<100 is normal) 130-159 is borderline high; 160-189 is very high Hdl 38 (40-59 is normal but higher is better) <40 is at increased risk of cardiac disease 5'8" weight: 220 pounds; BMI 33.5 vital signs: BP 146/90 P 70 Sao2 97% Random glucose finger stick in office: 130mgs/dl Less than 70 for LDL There’s no abnormal physical findings in the respiratory system to suggest early heart failure. But mild JVD present with trace edema in lower extremities. Eats out a lot - processed food, social drinking, occasional cigarette weekly; stopped Lisinopril one month ago, refuses HLD medication, will control with diet and exercise, allergy to METFORMIN 1. What Leads Demonstrate the ST Depression? 2. Is Lorene Hypertensive per ACA 2017 Guidelines? Compare the ACA guidelines to JNC 8 guidelines and discuss what treatment you recommend for her BP and why. 3. What is the Primary diagnosis causing Lorene's chest pain? Include ICD 10 codes (no differentials) 4. What other secondary diagnoses does Lorene have that should be addressed? (Include the rationale and a reference for your diagnoses) 5. Design a treatment plan and discuss how each intervention is applicable to Lorene's case. Consider the following interventions: ○ Labs ○ Durable Medical Equipment Diagnostic tests- discuss the goal/purpose ○ Any consultation with outside providers/services ○ Medications- discuss why you chose each specific medication 6. Referrals- who and why 7. Follow up- why and when 8. Education- specific and measureable 9. Lifestyle Changes- specific to her cultural preferences, values and beliefs Dr. Deering and class,1. Leads I, II, and V2 to V6 demonstrate ST depression. 2. Lorene’s elevated blood pressure of 146/90 places her at stage 2 hypertension based on the American College of Cardiology (ACC) 2017 guidelines. Essential (primary) hypertension (ICD I10) would be one of Lorene’s secondary diagnoses. The ACC 2017 guidelines differ from the Eight Joint National Commision (JNC 8) guidelines in the blood pressure classification, as well as blood pressure goal targets based on age and comorbidities. Regardless of age and whether the patient has diabetes and/or chronic kidney disease (CKD), the ACC 2017 guidelines recommend a blood pressure goal of less than 130/90. For patients 60 years and older, JNC 8 guidelines recommend pharmacologic treatment for blood pressure goal of less than 150/90 (Armstrong, 2014). For patients younger than 60 years old, JNC 8 guidelines recommend a blood pressure goal of less than 140/90. The blood pressure goal of less than 140/90 is also recommended for patients who have CKD or diabetes (Armstrong, 2014). While primary hypertension is often asymptomatic, long term hypertension increases the risk of developing a host of health complications, including coronary artery disease, heart failure, stroke, peripheral vascular disease, and vision loss (Woo & Robinson, 2016). The initial pharmacologic treatment for both guidelines is similar, which includes thiazide diuretics, angiotensin-converting enzyme inhibitors (ACEI), angiotensin receptor blockers (ARB), and calcium channel blockers (CCB) (Armstrong, 2014). While the use of ACEI is considered first line, studies have shown that adverse effects of ACEI, such as cough and angioedema, are more prevalent in the African American population (Messerli, Bangalore, Bavishi, & Rimoldi, 2018). Angioedema, a rapid swelling under the skin, occurs in less than 1% of patients who take ACEI, but it occurs more frequently in African Americans. Since angioedema can be life-threatening as it may impair breathing with tongue or throat swelling, a thiazide diuretic is an appropriate substitute to help lower blood pressure (Messerli et al., 2018). Even though Lorene’s hemoglobin a1C is at the higher end of pre-diabetes, I would consider and treat Lorene as a diabetic especially with an elevated fasting blood glucose. The risk of developing type 2 DM is increased with a prediabetes diagnosis, especially if appropriate measures are not taken to optimize glycemic control. Currently, the JNC 8 guidelines recommend a